News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Regulatory (World)
GENFIT (ALGFT): Successful Identification Of ROR?t Inverse Agonists As Candidates For Regulatory Pre-IND Studies 9/23/2016
35 U.S. States Sue British Drugmaker Indivior Over Marketing of Opioid 9/23/2016
Ireland Makes Its Case to Be New Home for the EMA Following Brexit 9/23/2016
FDA Takes Back Special Protocol Assessment for Active Biotech (BTPC)'s Laquinimod 9/19/2016
Bone Therapeutics Receives Positive Ruling On Belgian Patent Income Deduction 9/15/2016
Johnson & Johnson (JNJ) Announces WHO Will Review Ebola Vaccine Regimen For Emergency Use Assessment And Listing (EUAL) 9/13/2016
Akari Therapeutics Announces Receipt Of Orphan Drug Designation For Coversin From The FDA For Treatment Of Paroxysmal Nocturnal Hemoglobinuria 9/12/2016
European Chemicals Agency Supports Novartis AG (NVS) Over Use of Toxic Chemical in Drugs 9/9/2016
Anatara Lifesciences Successful Completion of Target Safety Study 9/8/2016
Eppendorf Striving To Ensure All Labs Are Smart, Safe, And Stress-Free, With Eppendorf Advantage 9/6/2016
Alzheimer’s Research UK Release: Loss Of Research Funding Is Top Brexit Fear For Dementia Scientists 9/6/2016
Evonik Birmingham Laboratories Receives Renewal Of GMP Certification 8/31/2016
Health Canada Moving Quickly To Control Chemicals Used To Make Fentanyl 8/31/2016
Shuwen Biotech Release: Chinese FDA Grants MammaTyper Innovative Product Status For Expedited Approval 8/19/2016
WuXi AppTec's STA Subsidiary Passed Third U.S. FDA Inspection 8/15/2016
CFDA Will Require Pharmas To Self-Report Any Drug Manufacturing Changes 8/15/2016
Wockhardt (WOCKHARDT.BO) Plunges On U.S. Ban On Third Drug-Making Factory 8/8/2016
Jazz Pharma (JAZZ) Release: CMS Grants New Technology Add-On Payment To Defitelio For The Treatment Of Hepatic Veno-Occlusive Disease With Renal Or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation 8/3/2016
Vascular Insights Release: NICE Issues Approval Via Interventional Procedure Guidance IPG557 For Endovenous Mechanochemical Ablation For Varicose Veins In The United Kingdom 7/25/2016
Royal Philips Electronics N.V. (PHG) SimplyGo Mini Portable Oxygen Concentrator Conforms To FAA Standards, Now Available For On Board Aircraft Use 7/21/2016
Two More Envigo Facilities Earn AAALAC Accreditation 7/20/2016
Vascular Insights Release: National Institute For Health And Care Excellence (NICE) Issues Approval Via Interventional Procedure Guidance IPG557 For Endovenous Mechanochemical Ablation For Varicose Veins In The United Kingdom 7/14/2016
Cynosure (CYNO) Receives Health Canada Authorization To Market SculpSure 7/13/2016
Health Canada Allowing Immediate Access To Naloxone Nasal Spray 7/7/2016
Health Canada Release: Government Of Canada Proposes Stronger Rules For Antimicrobial Drugs 7/1/2016
Health Canada Release: Mandatory Reporting Of Drugs Shortages And Discontinuances On Track For Spring 2017 Implementation 6/30/2016
Cytori Therapeutics (CYTX) Cell Therapy Receives Limited Approval For Osteoarthritis In Japan 6/27/2016
Chinese Authorities Issued Operating Approval To Siegfried Nantong 6/27/2016
British Trade Group Suspends Astellas (ALPMY) After Drugmaker Disguised the True Purpose of a Meeting Held for Doctors 6/27/2016
Rosetta Genomics (ROSG) Receives Approval From New York State For HEME FISH-Based Assays 6/21/2016
Shire (SHPG) Announces Completion Of Decentralized Procedure In Europe For Immunoglobulin Treatment Cuvitru 6/13/2016
EU Rules on Medical Devices Reached Sooner than We Thought 6/7/2016
Cristalia Obtains Registration For First Biotechnological Pharmaceutical Ingredient 6/7/2016
Test The Right Way At The Right Time: Mettler-Toledo (MTD) Offers Free Standard Operating Procedures For Routine Balance Testing 6/7/2016
Innovus Pharma To Request Regulatory Guidance For Filing For Its FlutiCare Product In Europe For The Treatment Of Allergic Rhinitis 6/3/2016
Vexos Shenzhen China Facility Achieves ISO 13485:2003 Registration Of Its Quality Management System 6/2/2016
TSO3 (TOS) Responds To U.S. Regulators On Extended Claims And Provides Operations Update 6/2/2016
Janssen Pharmaceutica N.V. Release: New Idylla Ebola Virus Triage Test Granted Emergency Use Authorization by U.S. FDA 6/1/2016
China Announces NDRC Investigation Into Drug/Device Pricing 6/1/2016
Pixium Vision Receives Clinical Trial Approval From UK Regulatory Authority For 150 Electrode IRISII Bionic Vision System 5/31/2016
Oxitec CEO To Testify Before Congressional Committee On May 25th 5/23/2016
Valeant (VRX) Provides Update Regarding Regulatory Matters 5/17/2016
Health Canada To Propose Regulatory Change To Enable Consideration Of Applications Under The Special Access Programme To Facilitate Treatment Of Chronic Relapsing Opioid Dependence 5/16/2016
WuXi AppTec's Pharmaceutical Development Service And Analytical Service Passes European Medicines Agency Inspection 5/12/2016
Lungpacer Medical, Inc. Receives Expedited Access Pathway Designation From FDA For The Lungpacer Diaphragm Pacing System 5/11/2016
Kitov (KTOV) Reports KIT-302 Study Successfully Meets FDA Bioequivalence Standards 5/10/2016
MGB Biopharma Limited's Pre-IND Meeting With FDA Provides Clear Guidelines On Further Development Of Oral MGB-BP-3, A Truly Novel Antibiotic Targeting Clostridium Difficile Infections 5/9/2016
Valeant (VRX) Announces Patient Access And Pricing Committee To Oversee Pricing Of Drugs 5/6/2016
ImmunID Receives CLIA Certification From The US Centers For Medicare & Medicaid Services 5/3/2016
Austrianova Facility Commissioned For GMP Manufacturing 4/25/2016
ACT Genomics Receives CAP Accreditation, Offering Full-Scale And Comprehensive Clinical Services To Transform Cancer Care 4/18/2016
ESMO Welcomes Final Version Of European General Data Protection Regulation 4/15/2016
Valeant (VRX) Provides Update Regarding Regulatory Matters 4/14/2016
OWC Pharmaceutical Research Corp. Comments On Israel's Proposed Medical Cannabis Guidelines 4/12/2016
WuXi AppTec Lab Testing Division's Analytical And Stability Testing Facilities Passed FDA Inspection 4/11/2016
SELLAS Life Sciences Group Receives A Favorable Opinion For European Orphan Drug Designations For WT1 Cancer Vaccine (galinpepimut-S) For The Treatment Of Acute Myeloid Leukemia And For Malignant Pleural Mesothelioma 4/5/2016
Valeant (VRX) Ad Hoc Committee Announces Completion Of Its Review Of Philidor And Related Accounting Matters 4/5/2016
Mezzion (140410.KQ) Receives Special Protocol Assessment (SPA) Agreement From FDA For Udenafil Phase 3 Studies In Adolescents With Single Ventricle Congenital Heart Disease With Fontan Physiology 3/24/2016
Aesica Comments On API Manufacturing Trends 3/24/2016
BioCorp: Announces Eligibility PEA-SME For 2016/2017 3/24/2016
WHO Issues Positive Recommendation For Oxitec's Self-Limiting Mosquito 3/21/2016
Cleveland Biolabs Inc. (CBLI) Provides Update On Pre-EUA Review Of Entolimod As Radiation Countermeasure 3/17/2016
Mass. Start-up Interscope Receives European Regulatory Approval, Secures Five U.S. Patents For Medical Devices Innovation 3/10/2016
Royal Philips Electronics N.V. (PHG) Meets Stringent U.S. Government Security Requirements For Pathology Medical Data 3/10/2016
Allergan (AGN) Receives Complete Response Letter From FDA For Prior Approval Supplement For RESTASIS (Cyclosporine Ophthalmic Emulsion) 0.05% Multi-Dose Preservative-Free Bottle 3/10/2016
Innovus Pharma Announces The Filing Of The Product License To Commercialize Androferti With Health Canada 3/9/2016
Whistle-Blower Of Unsafe Medicines Takes On "Made In India" 3/8/2016
Cellect Announces Receipt Of IRB Approval To Conduct Its Clinical Trial In Leukemia Patients 3/7/2016
Bedfont Scientific Responds to FDA's Decision to Temporarily Detain Its Products 3/1/2016
Health Canada Issues Notice Of Compliance For Gilead (GILD)'s Truvada For Reducing The Risk Of Sexually Acquired HIV Infection 2/29/2016
XYMOGEN Earns Prestigious Australian TGA Certification 2/25/2016
Firstkind, A Sky Medical Technology Company, Is Delighted To Announce RCN Accreditation Of Its User Training Programme For The geko Device For VTE Prevention 2/25/2016
tesa Labtec GmbH Announces Successful Completion Of FDA Pre-Approval Inspections Of Its R&D And Manufacturing Facilities 2/24/2016
Luminex (LMNX) Receives Medical Device License For ARIES System And ARIES HSV 1&2 Assay In Canada 2/23/2016
BioConnected Licenses Valencell's PerformTek Sensor Technology To Bring Next-Gen "Smart" Earphones To Market 2/23/2016
Neogen Corporation (NEOG)'s ANSR For Listeria Receives AFNOR Validation 2/16/2016
PharmaMar S.A. Release: The Phase III Clinical Trial Using PM1183 In Treating Ovarian Cancer (CORAIL) Continues Following The IDMC's Positive Recommendation 2/8/2016
Takeda (TKPYY) Release: FDA Psychopharmacologic Drug Advisory Committee Supports the Effectiveness of Brintellix (vortioxetine) in Treating Certain Aspects of Cognitive Dysfunction in Major Depressive Disorder (MDD) 2/4/2016
Telesta (TSX:TST) Receives Complete Response Letter From FDA 2/2/2016
Intersect ENT Announces NUB Status 1 Designation For PROPEL Sinus Implant In Germany 1/29/2016
Sinovac Biotech Ltd. (SVA) Announces Issuance Of GMP Certificate For EV71 Vaccine 1/28/2016
BioLineRx Ltd. Receives Confirmation Of Medical Device Classification In Europe For Celiac Treatment 1/25/2016
Zecotek Photonics Inc. Granted U.S. Notice Of Allowance For Enhanced LFS Crystal Array Manufacturing 1/15/2016
BioAmber Inc. Sarnia Certified To ISO 9001, ISO 14001, OHSAS 18001 And FSSC 22000 1/14/2016
Orchid Pharma Stock Surges on U.S. FDA Inspection Report for TN Unit 12/31/2015
Materialise Receives FDA NSE Letter for X-Ray 510(k) Submission 12/22/2015
TWi Pharmaceuticals, Inc. Receives Favorable Decision From The U.S. Court Of Appeals For The Federal Circuit Regarding TWi's Generic Version Of MEGACE ES 625mg/5ml 12/16/2015
BeiGene Selects GE Healthcare’s FlexFactory Biomanufacturing Platform For Pilot cGMP Production Facility In China 12/16/2015
Vetter Receives Internationally Recognized AEO-F Certificate For Global Movement Of Goods 12/1/2015
SkylineDx Receives CE-IVD Mark For MMprofiler -- Its Innovative Gene Signature-Based Test For Multiple Myeloma 11/25/2015
Medibio’s Study With Johns Hopkins University School of Medicine Receives IRB Approval 11/24/2015
Hikma (HIK.L) Announces Successful Resolution To FDA Warning Letter At Its Portugal Facility 11/18/2015
ScinoPharm Changshu Site Completed US FDA Inspection 11/9/2015
China Cord Blood Corporation Guangdong Subsidiary Has Been Accredited By American Association Of Blood Banks 10/30/2015
BioPharm Executive: From Bad to Worse: Biotech's Next Political Headache? 10/29/2015
Bavarian Nordic (BAVA.CO) Announces Expansion Of IMVAMUNE Orders From Canadian Government 10/28/2015
TSO3 Allowed Expanded Claims For Revolutionary STERIZONE VP4 Sterilizer 10/26/2015
goBalto, Inc. Release: New European Clinical Trial Regulations Aim To Reduce Administrative Burden And Costs 10/21/2015
China Biologic Products Received Operating Permit For New Branch Collection Facility In Shandong Province 10/20/2015
Successful Australian TGA Inspection Of Asymchem's Dunhua Facility 10/5/2015
China Issues Rules For Approval Of Stem Cell Clinical Trials 9/11/2015
Mabion Begins Pre-Registration Scientific Advice With The European Medicines Agency 9/8/2015
Medigus (MDGS.TA) Announces American Medical Association's Publication Of New Category I CPT Code 9/8/2015
CFDA To Start 60-Day Approvals For INDs Of Oncology Drugs 8/28/2015
WuXi PharmaTech (WX)'s STA Subsidiary Receives First Approval From Japanese Regulatory Authorities 8/27/2015
Arcadia Biosciences (RKDA) Release: Verdeca’s HB4 Stress Tolerance Trait Completes FDA Early Food Safety Evaluation 8/26/2015
Agendia BV Release: NCCN Breast Cancer Guidelines Acknowledge MammaPrint’s Ability to Predict Prognosis 7/28/2015
IndiPharm Awarded Bionexus Status By Malaysian Biotechnology Corporation 7/28/2015
Cellular Biomedicine Group (CBMG) Announces Successful New Certifications For Proprietary Cell And Tissue Preservation Media Kits 7/27/2015
European Medicines Agency Release: Stimulating The Development Of Medicines For Children 7/23/2015
Indian CRO Quality Questioned, As Quest Life Sciences Warned by WHO for HIV Trial Fraud 7/9/2015
BGI Receives Accreditation From The College of American Pathologists 7/6/2015
Innocoll, Inc. (INNL) Announces Qualified Infectious Disease Product (QIDP) Designation For Cogenzia For The Adjunctive Treatment Of Moderate And Severe Diabetic Foot Infection 6/30/2015
Information Update - Health Canada Requests Quarantine Of Drugs Linked To Polydrug Laboratories Due To Data Integrity Concerns 6/25/2015
AOP Orphan Pharmaceuticals AG Strengthens Core CNS Specialty Business With High Promise In Movement Disorder Treatments 6/19/2015
Intellirod Spine Raises Capital And Obtains ISO Certification 6/16/2015
Information Update - Health Canada Requests Quarantine Of Drugs Linked To Zhejiang Hisun Pharma Due To Data Integrity Concerns 6/16/2015
AmpliPhi Biosciences Corporation (APHB)’s Bacteriophage Manufacturing Facility Receives cGMP Certification 6/3/2015
The FDA Accepts To Review Theraclion's Submission For Approval Of An Echopulse Pivotal Trial In The U.S. 6/3/2015
KCR Accomplishes ISO 9001:2008 Certification For All Company Services 5/26/2015
Sinovac Biotech Ltd. (SVA) Receives Site Inspection Notification For EV71 Vaccine Production Facilities 5/14/2015
European Medicines Agency And Evidera Release Draft Opinion On Two Patient-Reported Outcome (PRO) Measures For Evaluating New Treatments For COPD 5/11/2015
T-Bird Pharma Announces Health Canada License Renewal Including Full Authorization To Sell 5/7/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Gastric Cancer 5/6/2015
IDEAL CURES Becomes The First Indian Excipients Company To Receive Excipact Certification 5/4/2015
TWi Pharmaceuticals, Inc. USA Announces The Receipt Of State Sales Licenses From All 50 States In The U.S. 4/17/2015
Hospira Slapped Again By the FDA for Plant Problems 4/16/2015
Juniper Pharma Services Obtains Specials Licence 4/16/2015
T-Bird Pharma Inc. Announces Health Canada Submission For Second Production Facility 4/10/2015
Cellular Biomedicine Group (CBMG)'s Shanghai Facility Passes Fourth Consecutive CFDA Inspection 4/6/2015
Innate Pharma (IPH.PA ) : DSMB Recommends Continuation Of Effikir Trial With Two Arms 3/30/2015
European Medicines Agency Release: Gardasil 9 Offers Wider Protection Against Cancers Caused By Human Papillomavirus (HPV) 3/27/2015
Kemwell Announces Successful FDA Inspection 3/24/2015
InMed Receives Exemption Status From Health Canada 3/23/2015
THERAVECTYS Granted Authorization By The French National Agency For Medicines To Produce Lentiviral Vectors For Clinical Use And CAR-T Cell Therapies Under GMP Standards 3/23/2015
Stempeutics Receives Advanced Therapy Medicinal Product (ATMP) Classification From European Medicines Agency For Its Novel Stem Cell Drug 'Stempeucel' 3/23/2015
Mesoblast Limited (MSB.AX) Selected For Fast Track Access To Potential Investment Incentives In Japan 3/19/2015
Tianyin Pharmaceutical Co, Inc. Received Notice Of Non-Compliance With NYSE MKT Continued Listing Requirements 2/27/2015
Medicago, Inc. Awarded A Contract By The U.S. Department Of Health And Human Services To Explore Alternate Production Methods For Ebola Antibodies 2/24/2015
Fake Quote Scandal: Medical Marijuana Firm CEN Biotech Receives Major Setback 2/20/2015
Vexim Announces Successful GMP Inspection by Brazil's National Health Surveillance Agency 2/19/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Pancreatic Cancer 2/17/2015
Siegfried Announces Comprehensive Solution For The Hameln Facility’s Regulatory Issues 2/16/2015
T-Bird Pharma Inc. Announces License Renewal From Health Canada 2/10/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Filing For Orphan Drug Designation With The U.S. FDA For High Grade Gliomas In Pediatric Patients 2/9/2015
Horizon Pharma plc.  (HZNP) Announces Issuance Of VIMOVO® Related Patent With Protection To 2031 From United States Patent And Trademark Office 2/5/2015
Tianyin Pharmaceutical Co, Inc.'s JCM Updates On Import Registration For International Clients 1/26/2015
Neuland Labs Reports Another Successful FDA Audit And Wins 2015 CMO Leadership Award 1/26/2015
Tianyin Pharmaceutical Co, Inc. QLF Received GMP Certification 1/20/2015
Veloxis Pharmaceuticals A/S (VELO) Confirms Receipt Of U.S. FDA Administration Decision 1/13/2015
TPI QLF To Receive GMP Certification 1/8/2015
Tauriga Sciences Inc. (TAUG) Confirms That Canadian Trading Halt (Cease Trade) Has Been Lifted By Autorite Des Marches Financiers (Quebec Based Regulatory Authority) 1/8/2015
Buchang Pharma Visits Tianyin Pharmaceutical Co, Inc. Qionglai Facility 1/6/2015
Successful FDA Inspection At Hovione 12/18/2014
EXCLUSIVE: Sanofi Pasteur (SASY.PA) US CMO Says U.S. Regulators Most Interested in Four-Strain Flu Vax 12/18/2014
Anti-Infective Advisory Committee Recommends Approval Of Actavis' Ceftazidime-Avibactam 12/8/2014
Sanofi (SAN.PA) Chairman Says French Tax Burden Is Hindering Hunt For New CEO 12/8/2014
IntelGenx Corp. Grants Extension Of Marketing Exclusivity In The U.S. To Edgemont Pharmaceuticals, LLC. Of Forfivo XL(R) 12/5/2014
Fifteen Indians Blinded After Surgery With Suspected Infected Tools 12/5/2014
China, South Korea OK GlaxoSmithKline (GSK)'s $43B Covidien (COV) Buy 12/5/2014
GVK Biosciences Review: Some Member States Suspend Marketing Authorisations For Concerned Medicines 12/5/2014
ChemoCentryx, Inc. (CCXI) Granted EU Orphan Drug Designation For CCX168, An Orally Administered Complement C5a Receptor Inhibitor, For The Treatment Of Microscopic Polyangiitis And Granulomatosis With Polyangiitis, Two Forms Of ANCA-Associated Vasculitis 12/4/2014
WuXi PharmaTech Co., Ltd. Subsidiary Submits Application To The National Equities Exchange And Quotations In China To List On The New Third Board 12/4/2014
Maharashtra FDA Executes "Surprise Inspection Spree" On Hundreds Of Pharma Units 12/3/2014
Germany Bars Antibiotic Cephalosporin From Ranbaxy Laboratories (RANBAXY.BO)'s Madhya Pradesh Plant 12/3/2014
Rhinomed Mute Granted US FDA Registration 12/3/2014
Novartis AG (NVS)' Heart Failure Medicine LCZ696 Granted Accelerated Assessment By CHMP In Europe 12/2/2014
Relmada Therapeutics Receives Health Canada Clearance To Commence First Clinical Study Of D-Methadone 12/2/2014
Inventiva Receives Another Positive Opinion On Orphan Drug Designation In The European Union For IVA337 – For Idiopathic Pulmonary Fibrosis 12/2/2014
ImmunoCellular Therapeutics, Ltd (IMUC) Receives Positive Regulatory Feedback From European Medicines Agency On Advancing ICT-107 To Phase 3 Program 12/1/2014
FDA Priority Review Voucher Scheme Under Fire 11/26/2014
Beximco Pharmaceuticals Becomes First Bangladeshi Company To Receive GMP Approval From Health Canada 11/24/2014
Yabao Pharmaceuticals In-licenses China Rights To Parkinson's Drug Technology 11/21/2014
Servier Release: European Medicines Agency Recommends Measures To Reduce Risk Of Heart Problems With Corlentor/Procoralan (Ivabradine) 11/21/2014
National Institute for Clinical Excellence (NICE) Requests More Info On Novartis AG (NVS)'s Xolair To Treat Chronic Hives 11/20/2014
Endo Pharmaceuticals (ENDP) Announces Early Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Auxilium Pharmaceuticals (AUXL) 11/19/2014
Cell Source's Megadose Drug Combination Receives Regulatory Approval In Italy To Commence Human Clinical Trials 11/13/2014
U.S. FDA Sends Warning Letter To Cadila Pharmaceuticals 11/12/2014
Cardiome Pharma Corp. (COM.TO) Submits BRINAVESS® Reimbursement Dossier To Italian Authorities To Support Market Access 11/10/2014
Actavis (ACT) And Durata Therapeutics, Inc.  (DRTX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Durata 11/3/2014
Veloxis Pharmaceuticals A/S (VELO) Announces Tentative Approval Of Envarsus® XR 10/31/2014
Tianyin Pharmaceutical Co, Inc.'s QLF Updates On Its GMP Certification Progress 10/23/2014
Clanotech AB Receives Orphan Drug Designation In The EU 10/20/2014
Health Canada Issues Notice Of Compliance For Gilead Sciences, Inc. (GILD)'s Harvoni™ (ledipasvir/sofosbuvir), The First Once-Daily Single Tablet Regimen For The Treatment Of Genotype 1 Chronic Hepatitis C 10/17/2014
China Biologic Products Receives Approval For Commercial Manufacturing Of Human Prothrombin Complex Concentrate At Shandong Taibang Facility 10/17/2014
Health Canada Release: Safety Information On The Risk Of Blood Clots With Immunoglobulin Products 10/13/2014
National Institute for Clinical Excellence (NICE) Rejects Another Roche (RHHBY) Leukemia Drug Citing Data Uncertainties 10/6/2014
Rare Cancers Europe Calls For New Criteria To Be Used In Clinical Trials On Rare Cancer Treatments 10/2/2014
Information Update - Health Canada Takes Action To Stop Import Of Products From Three Sites In India 10/1/2014
U.S. Patent and Trademark Office Issues Can-Fite BioPharma (CFBI) Patent For CF102 In The Treatment Of Liver Regeneration And Function Following Surgery 9/30/2014
Tianyin Pharmaceutical Co, Inc.'s QLF Completes GMP Site Inspection By CFDA 9/29/2014
Information Update - Health Canada Requests Quarantine Of Products For Canadian Market From Apotex Inc. Facility In Bangalore, India 9/25/2014
Medunik Canada Announces Health Canada Priority Review Of PHEBURANE® Indicated For The Treatment Of Urea Cycle Disorders (UCD) 9/24/2014
KemPharm, Inc. Receives Health Canada Approval To Begin KP201 Clinical Trials In Canada 9/23/2014
OxThera, Inc. Release: Oxabact® Granted European Medicines Agency Orphan Drug Designation For Treatment Of SBS 9/23/2014
Natco Pharma Limited, Orchid Chemicals Hit With A Strong Dose Of FDA Medicine 9/19/2014
GlaxoSmithKline (GSK) Resolves Violation Issue At Montana Facility 9/18/2014
Novartis AG (NVS), Roche (RHHBY) Cry Foul On New Swiss Pricing System 9/16/2014
Alchem International Commits To Tropane Alkaloid Apis And Extends Production And Regulatory Support To Resolve Supply Gap 9/15/2014
FDA's Surprise Visit To Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS)'s Pressures Stock 9/12/2014



//-->